AbbVie has filed for approval of a regimen based on its Venclexta therapy for previously untreated patients with chronic lymphocytic leukaemia (CLL), in combination with an AstraZeneca drug. The ...

President Donald Trump’s approval rating dipped to 40%, a low point for his second term, in the latest Reuters/Ipsos poll released Wednesday, as two polls show Americans blame Republicans more than ...